A Phase I Dose-Finding Study of E7389 (Halichondrin B Analog) in Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 19 Dec 2011
At a glance
- Drugs Eribulin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Acronyms BOLD
- 19 Dec 2011 Actual patient number is 33 according to ClinicalTrials.gov.
- 09 Sep 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 09 Sep 2009 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.